Showing results (1-10 of 98) with videos related to
Sort By:
Pageof 10
Oncology Research and Treatment|November 28, 2016
Targeted Treatment of Esophagogastric CancerHans-Georg Kopp, Ralf-Dieter HofheinzBlood|April 30, 2014
Neutrophil homeostasis and its regulation by danger signalingStefan Wirths, Stefanie Bugl, Hans-Georg KoppAnti-Cancer Drugs|August 31, 2006
Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamideHans-Georg Kopp, Lothar Kanz, Joerg T HartmannClinical & Developmental Immunology|October 12, 2010
Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulationTheresa Placke, Hans-Georg Kopp, Helmut Rainer SalihJournal of Innate Immunity|March 18, 2011
Modulation of natural killer cell anti-tumor reactivity by plateletsTheresa Placke, Hans-Georg Kopp, Helmut Rainer SalihCurrent Opinion in Hematology|March 29, 2006
Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissueHans-Georg Kopp, Carlos A Ramos, Shahin RafiiOncoimmunology|July 4, 2012
The wolf in sheep's clothing: Platelet-derived "pseudo self" impairs cancer cell "missing self" recognition by NK cellsTheresa Placke, Hans-Georg Kopp, Helmut Rainer SalihCancer Research|September 10, 2009
Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivityHans-Georg Kopp, Theresa Placke, Helmut Rainer SalihJournal of Immunology (Baltimore, Md. : 1950)|June 1, 2012
GITR ligand provided by thrombopoietic cells inhibits NK cell antitumor activityTheresa Placke, Helmut R Salih, Hans-Georg KoppJournal of Cancer Research and Clinical Oncology|December 24, 2004
Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantationWichard Vogel, Hans-Georg Kopp, Lothar Kanz, et al.Pageof 10